RA-PR058 is an orally active Ramalin derivative with blood-brain barrier permeability, exhibiting multi-target regulatory effects and favorable pharmacokinetic properties. RA-PR058 demonstrates potential as a multi-target modulator for Alzheimers disease by reducing the expression of BACE1, tau protein hyperphosphorylation, and anxiety-like behaviors[1].
Molecular Weight:
297.70
Formula:
C11H15ClF3N3O
Target:
Beta-secretase,Tau Protein
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
